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Available online 9 March 2016Gastricmucosal damage induced by ethanol is a serious medical problem. Recent evidences suggest that reactive
oxygen species and inﬂammatory mediators play a key role in the destruction of gastric mucosa. The present
study was aimed to evaluate the potential beneﬁcial effect of MESNA (2-mercaptoethane sulfonate) against
ethanol-induced gastric mucosal damage in mice. The animals were orally pretreated with vehicle or MESNA
and then treated with acidiﬁed ethanol to induce gastric mucosal damage. One hour after ethanol ingestion
micewere euthanized and stomach sampleswere collected for biochemical analysis. Macroscopic and histopath-
ological evaluation of gastric mucosa showed that pretreatment with MESNA attenuated gastric lesions induced
by ethanol. Administration of MESNA signiﬁcantly increased glutathione content and superoxide dismutase and
catalase activity in the gastric tissues. In addition, MESNAmarkedly reduced ethanol-induced lipid peroxidation,
myeloperoxidase activity, tumor necrosis factor-alpha, interleukin (IL)-1β, IL-6, and monocyte chemotactic
protein-1 levels. These ﬁndings suggest that the thiol-containing compound MESNA is able to decrease
alcohol-induced oxidative stress and inﬂammation in the gastric tissue. It seems thatMESNAmay have a protec-
tive effect against ethanol-induced gastric mucosal damage.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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Ethanol1. Introduction
Gastric ulcer is the most prevalent gastrointestinal disorder that af-
fects many people worldwide. Although the mechanism of gastric
ulcer has not been completely elucidated, it is shown that the gastric
mucosal injury results from an imbalance between aggressive and
protective factors. The risk factors that contribute to the formation of
gastric lesions include consumption of alcohol, non-steroidal anti-
inﬂammatory drugs (NSAIDs), increased secretion of hydrochloric
acid, Helicobacter pylori, stress, and tobacco [1]. It has been established
that ethanol as an exogenous irritant damages the gastrointestinal mu-
cosal cells and leads to gastric ulcers by different molecular mecha-
nisms. Experimental and clinical studies showed that the reactive
oxygen species (ROS) and inﬂammatory mediators induced by ethanol
contribute to the pathogenesis of ethanol mediated gastric lesions.
After entering cells, ethanol is metabolized and facilitates production
of the superoxide anion (O2•−), hydrogen peroxide (H2O2) and hydroxyl
free radical (HO•). Generation of highly reactive oxygen species induces
lipid peroxidation of cellular membranes and leading to cell death and
epithelial damage. Furthermore, in the gastric mucosal cells, ethanolgy, School of Pharmacy, Ardabil
141, Iran.
i).signiﬁcantly reduces the levels of major antioxidants that can eliminate
reactive oxygen species [2,3]. It has also been demonstrated that neutro-
phil inﬁltration into the gastric mucosa and release of proinﬂammatory
cytokines such as TNF-α, IL-1β, IL-6 and chemokineMCP-1 are involved
in the pathogenesis of gastric mucosal injury [4–7].
Recently, many studies have focused on novel approaches for pre-
vention of gastric mucosa from alcohol-induced injury. Several com-
pounds with antioxidant and anti-inﬂammatory activity have been
studied for their gastroprotective effects [3,5,6,8,9]. 2-Mercaptoethane
sulfonate (MESNA) is a small, synthetic, sulfhydryl-containingmolecule
that has the ability to scavenge reactive oxygen species through its an-
tioxidant effects. MESNA is frequently used with cyclophosphamide
and ifosfamide to reduce hemorrhagic cystitis induced by acrolein, a
toxic urinarymetabolite of oxazaphosphorine-alkylating agents. Sulfhy-
dryl group present in MESNA binds to acrolein within the urinary tract
and forms nontoxic stable thioether that is safely eliminated in the
urine. Adverse effects associatedwithMESNA are few andwell tolerated
bymost patients. Several studies have been shown that MESNA is effec-
tive in the treatment of oxidative stress induced disorders. It has been
reported thatMESNA prevents doxorubicin-induced plasma protein ox-
idation, cisplatin-induced ovarian damage and ischemia reperfusion-
induced oxidant damage of the intestinal mucosa [10–12]. The present
studywas aimed to investigate the effectiveness and the possiblemech-
anisms of action of MESNA in amousemodel of ethanol-induced gastric
mucosal damage.
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2.1. Animals
Experiments were performed on male Swiss albino mice weighing
26–30 g. Animals were kept in our animal house under controlled con-
ditions and allowed free access to tap water and a standard diet. Mice
were fasted overnight with free access to water before the induction
of gastric mucosal lesions. All animal procedures were carried out in ac-
cordance with the National Institute of Health's Guide for the Care and
Use of Laboratory Animals (NIH publication 85–23, revised 1996).
2.2. Materials
5,5′-Dithiobis-2-nitrobenzoic acid, tetramethylbenzidine, glutathi-
one reduced, Tris–HCl buffer, hydrogen peroxide, thiobarbituric acid,
trichloroacetic acid and 1,1,3,3-tetraethoxypropane were purchased
from Sigma-Aldrich.MESNAwas obtained from Baxter (Germany). Eth-
anol was purchased from Taghtir Co. (Iran). Protease inhibitors (Com-
plete Mini tablets) were purchased from Roche (Germany).
2.3. Experimental design
Intragastric administration of ethanol/HCl has long been used as an
experimental method to induce gastric mucosal damage in animals.
HCl in ethanol solution accelerates the progress of ulcerogenesis and en-
hances ethanol-induced gastricmucosal toxicity [13,14].Micewere ran-
domly allocated into four groups (8mice each). The ﬁrst group received
normal saline orally and served as the control group. The second group
of mice was given MESNA alone. The third group of mice was given a
single dose of acidiﬁed ethanol. The fourth group was given
400 mg/kg MESNA and acidiﬁed ethanol. MESNA administered orally
1 h before application of the ulcerogenic agent. One hour after treat-
ment with MESNA the animals received acidiﬁed ethanol (60% etha-
nol/0.3 M HCl, 0.1 ml/10 g body weight, orally) to induce gastric
mucosal injury. The dose of MESNA used in this study (400 mg/kg)
was selected based on our preliminary experiments and previous stud-
ies [15,16].
2.4. Sample collection
One hour after administration of ethanol/HCl mice were anesthe-
tized with ketamine and xylazine and their stomachs were excised.
The stomachs were opened along the greater curvature and gently
washed with cold saline solution to remove the gastric contents. The
gastric tissue samples were frozen in liquid nitrogen and kept at
−80 °C for biochemical determinations.
2.5. Determination of gastric mucosal injury index
Macroscopic scoring of gastric mucosal damage was performed by
light microscopy. The severity of gastric damage induced by ethanol/
HCl was expressed as an ulcer index (UI) and calculated based on the
number and diameter of the lesions [13]. UI = Σ(A) + (2B) + (3C) (A
is the number of small lesions up to 1 mm; B is the number of lesions
up to 3 mm; and C is the number of linear lesions N3 mm). The mean
ulcer index was calculated for each group and then statistically
analyzed.
2.6. Histopatological analysis
A small specimen of each stomach was ﬁxed in 10% formalin and
embedded in parafﬁn, and sections were stained with hematoxylin
and eosin (H&E). The histopathology examination was performed
under light microscopy by an experienced pathologist according to the
method as described previously [17]: (1) hemorrhage (score 0–4),(2) mucosal edema (score 0–4), (3) epithelial cell loss (score 0–3),
and (4) inﬂammatory cell inﬁltration (score 0–3).
2.7. Preparation of gastric tissue homogenate
The gastric tissues were cut into small pieces and homogenized in
ice-cold Tris–HCl buffer (pH 7.4, containing protease inhibitor cocktail)
using a homogenizer (Heidolph, Germany). The homogenates were
centrifuged at 20,000 ×g for 20 min in a refrigerated centrifuge at
4 °C. The supernatants were collected and stored at −80 °C until
analysis.
2.8. Measurement of malondialdehyde (MDA) levels
Gastric tissue MDA level was determined using the thiobarbituric
acid method as described in our previous study [4]. Brieﬂy, 100 μl of
the supernatant was added to a reaction mixture containing 100 μl of
20% (w/v) trichloroacetic acid (TCA) and 100 μl of TBA (0.1M). Themix-
ture was incubated in a boiling water bath for 60 min to complete the
reaction. After cooling, the samples were centrifuged at 10,000 ×g for
5 min at 4 °C and the supernatants were separated from the pellets.
The absorbance of the supernatants was measured at 532 nm using a
96-well microplate reader (BioTek, USA).
2.9. Measurement of reduced glutathione (GSH) content
To determine GSH, 50 μl of 10% trichloroacetic acid (TCA)was added
to 50 μl of the supernatant to precipitate the proteins. The mixture was
centrifuged at 10,000 ×g for 5 min at 4 °C and the supernatants were
separated from the pellets. 50 μl of the resulting supernatant was
added to 150 μl of DTNB (5,5′-Dithiobis-2-nitrobenzoic acid) in phos-
phate buffer (0.2 M, pH 7.6, 1 mM EDTA). The intensity of the yellow
color formed was read at 412 nm using a microplate reader.
2.10. Measurement of superoxide dismutase (SOD) activity
The activity of superoxide dismutase in gastric supernatant samples
was measured using a SOD assay kit (BioVision) according to the
manufacturer's protocol.
2.11. Measurement of catalase (CAT) activity
CAT activity was assessed according to themethod as described pre-
viously [18]. Brieﬂy, 10 μl of the supernatantwas added to a cuvette con-
taining 0.5 ml of phosphate buffer (50 mM, pH 7). Reaction was started
by the addition of 0.5 ml of H2O2 (30 mM). The rate of change in absor-
bance was measured at 240 nm and CAT activity was deﬁned as the
quantity of enzyme degrading 1 mmol of H2O2 per minute.
2.12. Measurement of myeloperoxidase (MPO) activity
The activity of MPO in gastric tissue samples was determined ac-
cording to our previous study [4]. Brieﬂy, The reactionmixture for anal-
ysis consisted of 50 μl sample, 50 μl of 15 mM tetramethylbenzidine
(TMB) and 100 μl of hydrogen peroxide (25 mM) diluted in phosphate
buffer (50 mM, pH 5.4). The assay was performed in a microplate and
the reaction was started by adding hydrogen peroxide. The rate of
change in absorbance was measured at 370 nm and MPO activity was
deﬁned as the quantity of enzyme degrading 1 μmol of hydrogen perox-
ide per min at 25 °C.
2.13. Measurement of pro-inﬂammatory cytokines
The cytokine levels of TNF-α, IL-1β, IL-6 and MCP-1 were measured
by using mouse ELISA kit from eBioscience according to the
manufacturer's instructions.
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Data were presented as mean ± standard deviation (SD). Multiple
group comparisons were analyzed statistically by one-way analysis of
variance (ANOVA) with post hoc Tukey test. p b 0.05 was considered
statistically signiﬁcant.3. Results
3.1. Macroscopic examination
Macroscopic analysis of the gastric mucosa showed that oral admin-
istration of acidiﬁed ethanol produced extensive mucosal ulcerations in
the glandular portion of the stomach (Fig. 1a). Ulcers of the gastric mu-
cosa appeared as elongated bands of hemorrhagic lesions parallel to the
long axis of the stomach. Pretreatment of mice with a single dose
(400 mg/kg) of MESNA reduced mucosal damage induced by ethanol.
Additionally, as shown in Fig. 1c, MESNA treated group showed a signif-
icant decrease (p=0.002) in the gastric ulcer index as compared to eth-
anol group.Fig. 1. Effect of MESNA and ethanol in a mouse model of ethanol-induced gastric mucosal dam
gastric mucosa. The gastric tissue sections were analyzed by H&E staining (magniﬁcation is ×4
ulcer score± SD. (13.87± 4.2 for ethanol control group; 7.3± 4.25 forMESNA+ethanol group
mean of the total score± SD. (1.66± 0.85 for ethanol control group; 0.87 ± 0.7 forMESNA+ e
ethanol control group.3.2. Microscopic examination
Histopathological analysis of the gastric mucosa revealed that oral
administration of acidiﬁed ethanol induced gastricmucosal injury, char-
acterized by hemorrhagic damage, submucosal edema, loss of epithelial
cells and inﬂammatory cell inﬁltration (Fig. 1b). Animals pretreated
with MESNA showed less microscopic mucosal injury as compared
with the control group treated with ethanol. As shown in Fig. 1d, mice
pretreated with MESNA also showed a signiﬁcant decrease (p b 0.001)
in the total histopathological scores when compared with the ethanol
group. No histopathological alteration was observed in the stomach of
MESNA only-treated mice.
3.3. Effect of MESNA on MDA level and MPO activity
Oral administration of ethanol signiﬁcantly increased the content of
MDA and the activity of MPO in the gastric tissue in comparison to the
vehicle-treated control group (Table 1). Pretreatment with MESNA re-
markably reduced the formation of MDA (p = 0.001) and the level of
MPO (p b 0.001) in the gastric tissue compared with the ethanol
group. These data indicate that MESNA pretreatment is able to inhibitage. (a) Macroscopic appearance of the gastric mucosa. (b) Histological appearance of the
00). (c) Gastric mucosal ulcer index in each experimental group. The results are the mean
). (d) Total histopathological scores in the gastricmucosa. The results are presented as the
thanol group). #p b 0.001 compared with vehicle-treated group; *p b 0.01 compared with
Table 1
Effects of MESNA on the gastric tissue levels of MDA, MPO, GSH, SOD and CAT in four study groups.
Groups MDA
(nM/mg tissue)
MPO
(mU/mg tissue)
GSH
(nM/mg tissue)
SOD
(mU/mg tissue)
CAT
(mU/mg tissue)
Vehicle 24.5 ± 2.5 18.6 ± 1.47 3.5 ± 0.25 48.4 ± 2.78 62.3 ± 19
MESNA 23.17 ± 3.26 17.8 ± 3.39 3.74 ± 0.67 47.6 ± 2.57 65.6 ± 17
Ethanol 45.3 ± 8.7# 32.3 ± 5.1# 0.3 ± 0.26# 31.6 ± 8.4# 19.5 ± 5.7#
MESNA + ethanol 30.9 ± 6.76⁎⁎ 19.1 ± 2.3⁎⁎ 3 ± 0.42⁎⁎ 46 ± 6.5⁎⁎ 47.2 ± 7.4⁎⁎
Data are means ± SD.
# p b 0.01 compared with vehicle-treated group.
⁎⁎ p b 0.01 compared with ethanol control group.
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gastric mucosa.
3.4. Effect of MESNA on GSH, SOD and CAT levels
Measurement of gastric endogenous antioxidant GSH levels and SOD
and CAT activity showed that ethanol administration induced signiﬁ-
cant depletion of gastric contents of GSH, SOD and CATwhen compared
with those in the vehicle-treated group (Table 1). Pretreatment with
MESNA, signiﬁcantly restored the levels of GSH (p b 0.001) and SOD
(p b 0.001) and CAT (p= 0.002) activity in the gastric mucosa as com-
paredwith those in the ethanol group. These results demonstrate an an-
tioxidant effect of MESNA in this experimental model.
3.5. Effect of MESNA on pro-inﬂammatory cytokines
The levels of proinﬂammatory cytokines TNF-α, IL-1β, IL-6 and che-
mokine MCP-1 in the gastric mucosa were considerably elevated in the
ethanol treated group as compared to the vehicle-treated control group
(p b 0.001) (Fig. 2). Pretreatment of mice with MESNA signiﬁcantly de-
creased the production of TNF-α (p = 0.001), IL-1β (p b 0.001), IL-6
(p b 0.001) and MCP-1(p b 0.03) in the gastric tissue as compared to
the mice treated with ethanol. These ﬁndings show an anti-
inﬂammatory effect of MESNA in the gastric tissue.
4. Discussion
Chronic alcohol abuse can cause gastrointestinal toxicity including
gastric mucosal lesions. In the present work, we studied the
gastroprotective activity of MESNA in a mouse model of ethanol-
induced gastric mucosal damage. Oral administration of ethanol is com-
monly used as an experimental model of gastric mucosal injury inmice.
We found that application of acidiﬁed ethanol caused macroscopic gas-
tric lesions and pretreatment with MESNA signiﬁcantly reduced gastric
mucosal lesions induced by ethanol. The gastroprotective effect of
MESNA was further conﬁrmed by histopathological examination.
Ethanol induces its toxic effects primarily by oxidative stress and
subsequent inﬂammatory mechanisms. Several studies have shown
that ethanol administration induces oxidative stress by increasing the
production of reactive oxygen species and depletion of cellular antioxi-
dant capacity. Ethanol also induces the activity of cytochrome P450 en-
zymes, which contribute to the generation of oxygen radicals. It has
been shown that ethanol-induced reactive oxygen species, in particular
superoxide anion (O2•−), is derived from mitochondria [2]. These highly
toxic oxygen species are extremely reactive and cause damage to pro-
teins, lipids and DNAwhich ultimately results in cell death. Lipid perox-
idation is an important mechanism of cellular injury and many studies
have demonstrated that ethanol can induce lipid peroxidation in cell
membranes through reactive oxygen species [19]. Ethanol induced
lipid peroxidation in gastric epithelial cells triggers the loss of mem-
brane integrity, increase in cell permeability and leads to acceleration
of gastric ulcer formation. Malondialdehyde (MDA) is an end-product
of the peroxidation of polyunsaturated fatty acids within cellmembranes, and commonly used as a reliable marker of lipid peroxida-
tion process in tissues. Therefore, determination of MDA levels can be
used to estimate the degree of ethanol-induced gastric damage. In the
present study, we found that ethanol administration signiﬁcantly in-
creased the production of MDA in the gastric tissue. This result is in
agreement with other studies, which revealed that the concentration
of MDA in the gastric tissue can be elevated by ethanol administration
[3,8,9]. Pretreatment with MESNA signiﬁcantly prevented the ethanol-
induced increase of MDA levels in the gastric tissues. This ﬁnding
shows an antioxidant activity of MESNA and may indicate that MESNA
reduces alcohol-induced gastric injury through the preventing of lipid
peroxidation process.
The cells of the gastrointestinal mucosa have endogenous antioxi-
dant systems which protect cells against reactive oxygen species. Anti-
oxidant enzymes involved in the elimination of oxygen radicals
include superoxide dismutase (SOD) and catalase. The enzyme SOD cat-
alyzes the dismutation of superoxide anions (O2•−) into oxygen (O2) and
H2O2. Hydrogen peroxide could be enzymatically metabolized into oxy-
gen and water by catalase [20]. It has been shown that the tissue levels
of SOD and catalase was decreased in ethanol-induced gastric damage
and increased during treatment. SOD and catalase act as an important
antioxidant defense in the gastric cells against ethanol induced oxida-
tive stress [21,22]. Reduced glutathione (GSH) is a critical cellular anti-
oxidant, and plays an important role in intracellular protection against
toxic compounds. The antioxidant properties of GSH are due to the pres-
ence of the sulfhydryl (SH) group in its structure. GSH acts as a reactive
oxygen species scavenger and inhibitor of lipid peroxidation and serves
as a cofactor for glutathione S-transferase enzymewhich removes toxic
compounds by binding with GSH. It has been demonstrated that GSH is
involved in a variety of cellular functions such as regulation of cell sig-
naling and DNA repair mechanisms [23]. It has been proven that
ethanol-induced gastricmucosal damage is associatedwith a signiﬁcant
decrease in GSH content of the gastric tissue. Depletion of GSH results in
accumulation of reactive oxygen species, enhanced lipid peroxidation,
andDNA damage [24]. In our study, acute ethanol administration signif-
icantly decreased gastric levels of GSH and SOD and catalase activity,
which is in agreement with other studies [3,22]. The reduction in SOD
and catalase activity might be attributed to the enzyme consumption
due to neutralizing the excessive superoxide anions in the gastric tis-
sues. The depletion of GSH content may result from its consumption
by detoxifying ethanol-induced oxygen species and toxic products.
MESNA pretreatment prevented the depletion of GSH and restored
SOD and catalase activity in the gastric mucosa damaged by ethanol.
These results suggest that the ability to increase GSH content and SOD
and catalase activity is an important mechanism of action of MESNA.
In other words, this ﬁnding conﬁrms that the gastroprotective effect of
MESNA in this experimental model is mediated through an antioxidant
mechanism.
It has been shown that ethanol induces the inﬁltration of neutrophils
into the gastric mucosa. Neutrophils are an important source of reactive
oxygen radicals and play a critical role in the development of gastric
mucosal damage. The enzymemyeloperoxidase (MPO) is a biochemical
marker of neutrophil inﬁltration in the injured tissue. This enzyme is a
Fig. 2.Effect ofMESNA on (a) TNF-α, (b) IL-1β, (c) IL-6 and (d)MCP-1production in gastric tissue ofmice. Administration of ethanol increased the levels of TNF-α, IL-1β, IL-6 andMCP-1 in
gastric tissue, whereas pretreatmentwithMESNA (400mg/kg) prevented the ethanol-induced increase in TNF-α, IL-1β, IL-6 andMCP-1. Results aremeans± SD. Themean and SD values
of ethanol control andMESNA+ethanol groups, respectively, are 24.4± 6.6 and 13.8± 1.6 in TNF-α, 6.6± 1.7 and 4± 0.5 in IL-1β, 33.5± 7.4 and 22.7± 2.7 in IL-6, 5.5± 1.7 and 3.9±
0.4 in MCP-1. #p b 0.01 compared with vehicle-treated group; **p b 0.01 compared with ethanol group.
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Following degranulation of neutrophils, MPO is released and catalyzes
the oxidation of chloride ion with hydrogen peroxide (H2O2) to form
hypochlorous acid (HOCl), which is a cytotoxic free radical [25–27]. In
the present study, ethanol administration signiﬁcantly increased the
MPO activity, which represents inﬁltration of neutrophils into the gas-
tric tissue. The increase of MPO activity in the gastric mucosal tissue
may also be explained by the increase in the oxidative stress caused
by ethanol. Pretreatment with MESNA prevented the increase of MPO
activity in the gastric tissue of animals receiving ethanol. Other studies
have also shown that MESNA is able to inhibit MPO activity in tissues
[16,28]. The protective effect of MESNA against ethanol-induced gastric
mucosal damagemay be partially described by the ability of this drug to
reduce neutrophil inﬁltration and MPO activity.
Ethanol-induced gastric mucosal damage was accompanied by the
signiﬁcant increase in the levels of proinﬂammatory cytokines, such as
TNF-α, IL-1β, IL-6 and MCP-1. It has been shown that the production
of TNF-α is one of the earliest events in ethanol-induced gastric injury.
This pro-inﬂammatory cytokine triggers the production of other cyto-
kines and activates inﬁltration of neutrophils which aggravate tissue
damage through release of reactive oxygen species [5,6]. Moreover, it
has been reported that ethanol-induced gastric epithelial cell apoptosis
is associatedwith the increase of mucosal TNF-α levels [29]. IL-6 and IL-
1β are pleiotropic inﬂammatory cytokines that express during gastric
inﬂammation and enhance the effects of oxidative stress. It has been
suggested that these inﬂammatory cytokines may trigger the oxidative
pathways responsible for tissue damage in gastric ulcer disease [4,8].
The MCP-1 is a member of the chemokine family, and the most potent
chemotactic factor for monocytes. It has been demonstrated that MCP-
1 plays a key role in the initiation of mucosal inﬂammatory responsesduring the development of gastric mucosal injury. Inﬂammatory cells
such as macrophages are the main source of MCP-1. Increased produc-
tion of MCP-1 may be due to an increase in the number and activation
of macrophages in injured gastric mucosa [7]. Nuclear factor-kappa B
(NF-κB) is an important transcription factor that regulates inﬂammato-
ry processes and immune responses. NF-κB mediates the induction of
pro-inﬂammatory cytokines (e.g., TNF-α, IL-1B and IL-6), chemokines
(e.g., MCP-1) and several other adhesion molecules. It has been report-
ed that MESNA prevents ischemia-reperfusion-induced intestinal mu-
cosal damage by inhibition of NF-κB activation [12]. In the present
study, we showed that the oral administration of ethanol increased
the levels of proinﬂammatory cytokines TNF-α, IL-1β, IL-6 and chemo-
kineMCP-1 in the gastric tissue. PretreatmentwithMESNA signiﬁcantly
induced a decrease in the levels of these proinﬂammatory cytokines,
suggesting an anti-inﬂammatory effect of MESNA. It is important to
note thatMESNA have previously been shown to reduce TNF-α produc-
tion in various experimentalmodels, although the underlyingmolecular
mechanisms have not been fully understood [10,30].
In conclusion, the data presented in the current study suggest that
prophylactic administration of MESNA can attenuate the ethanol-
induced gastric mucosal damage. The gastroprotective effect of
MESNA may be primarily attributed to the decrease of lipid peroxida-
tion process, increase the antioxidant capacity, and inhibition of inﬂam-
matory responses. Further studies are needed to determine whether
MESNA could be used to protect against alcohol induced gastric damage
in humans.
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